SMARCC2 and Parkinson disease: We found an increase of neurons with SMARCC2+ cytobodies/mm2 in PD (13.5 ± 12.2 in PD vs 5.3 ± 5.0 in neurologically normal cases, p = 0.014) (Fig 2C).